Back

EMPEROR-Preserved - Discussant review.

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Hot Line - EMPEROR-Preserved / EMPEROR-Pooled Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Frank Ruschitzka

University Hospital Zurich, Zurich (Switzerland)

4 More presentations in this session

Presentation thumbnail
EMPEROR-Preserved: effect of empagliflozin on cardiovascular death and heart failure hospitalisations in patients with heart failure with a preserved ejection fraction, with and without diabetes
Professor S. Anker (Berlin, DE)
Slides Video
Presentation thumbnail
EMPEROR-Pooled: effect of empagliflozin on serious adverse renal outcomes in chronic heart failure – a prospective alpha-protected, Individual patient-level pooled analysis
Professor M. Packer (Dallas, US)
Slides Video
Presentation thumbnail
EMPEROR-Pooled - Discussant review.
Professor R. De Boer (Rotterdam, NL)
Slides Video
Presentation thumbnail
EMPEROR-Preserved / EMPEROR-Pooled - Panel discussion.

Access the full session

Session thumbnail
Hot Line - EMPEROR-Preserved / EMPEROR-Pooled
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021
You may be interested in
thumbnail
Congress Presentation
Pharmacotherapy in HFpEF: where do cardiometabolic drugs fit in?
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources